Last edition
News about "Dr. Karl Ziegelbauer"
China's NMPA approves Almirall's Seysara for Moderate-to-Severe Acne Treatment
China’s NMPA has approved Almirall’s Seysara (sarecycline hydrochloride), the first oral antibiotic developed specifically for acne, expanding access to innovative dermatology treatment in partnership with Sinomune.
Dr. Karl Ziegelbauer | 31/01/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members